Brokerages extend their focus across a broad spectrum of Indian stocks, highlighting growth opportunities and valuation challenges amid encouraging earnings reports and evolving market dynamics.
Brokerages turned their attention to a wide spread of Indian stocks on Monday, with fresh calls spanning healthcare, commercial vehicles, consumer durables, cement, defence, ports, railways, industrial equipment, online education and financial services. The notes were led by earnings updates and management commentary, with analysts also weighing in on broader themes including India’s growth strategy, foreign currency non-resident inflows and the non-life insurance market.
Max Healthcare drew a constructive view from Jefferies and Citi after both pointed to steady quarterly growth, even as oncology-related disruption continued to weigh on performance. Jefferies kept its buy rating and lifted its target price, saying the company’s revenue and EBITDA rose in line with expectations and that expansion plans remained on track, including the operational launch of Max Smart and the Kalinga Hospital acquisition. Citi also stayed positive, saying growth was supported by occupied bed days and that margins should improve as new beds ramp up. Separately, consensus data compiled by StockAnalysis suggests the market broadly shares that optimism, with an average target price above current levels.
Ashok Leyland was more mixed, with Jefferies holding its neutral stance while other houses remained more constructive. Jefferies said the quarter was subdued, with flat EBITDA and only modest profit growth despite higher volumes, and warned that valuations still look rich versus historical norms. Goldman Sachs, Citi, Kotak Institutional Equities, CLSA and UBS all pointed to resilient demand, pricing discipline and healthy market share, but also flagged margin pressure from higher commodity costs and inventory effects. The broader takeaway from broker notes was that volume momentum remains intact, yet the stock’s rerating now leaves less room for error.
Voltas also stayed in focus after Jefferies upgraded the stock’s target and highlighted a stronger share position in room air conditioners, with market share rising and channel inventories normalising. The brokerage said the company’s planned joint venture with Atomberg to make compressors could help secure supply in a tighter import environment. By contrast, Nomura stayed cautious, saying intense competition could delay any recovery in margins. Elsewhere, JSW Cement attracted buy calls from Citi and Jefferies after a quarterly earnings beat and management’s guidance for high-teens volume growth, though both noted pressure from marketing costs and the ramp-up of the new Nagaur plant. Jefferies said Nagaur should reach EBITDA breakeven by September 2026.
Other broker comments were spread across the market. Citi raised its view on M&M after the launch of the BE6 SPORTEQ and said the company continues to gain share in electric vehicles. Jefferies turned more cautious on Aegis Vopak Terminals after a strong run, arguing that valuation now limits upside despite solid execution and expansion plans. In defence, Goldman Sachs stayed negative on Bharat Dynamics even after a revenue beat, saying much of the execution upside is already in the price. J.P. Morgan raised its view on PhysicsWallah after a stronger quarterly print and continued revenue guidance, while Macquarie nudged up its target for Info Edge, citing better billings trends but still describing the valuation as demanding.
Disclaimer: This article is intended to inform and educate, not to recommend or endorse any financial product, investment or strategy. Please consider your own financial circumstances and seek professional advice where appropriate before making financial decisions.
